Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2377
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain ; volume:9 ; number:1 ; day:10 ; month:2 ; year:2009 ; pages:1-14 ; date:12.2009
BMC neurology ; 9, Heft 1 (10.2.2009), 1-14, 12.2009
- Creator
-
Quilici, Sibilia
- Contributor
-
Chancellor, Jeremy
Löthgren, Mickael
Simon, Dominique
Said, Gerard
Le, Trong Kim
Garcia-Cebrian, Ana
Monz, Brigitta
SpringerLink (Online service)
- DOI
-
10.1186/1471-2377-9-6
- URN
-
urn:nbn:de:1111-2016030326751
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Quilici, Sibilia
- Chancellor, Jeremy
- Löthgren, Mickael
- Simon, Dominique
- Said, Gerard
- Le, Trong Kim
- Garcia-Cebrian, Ana
- Monz, Brigitta
- SpringerLink (Online service)
Other Objects (12)
Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy
The Cost-Effectiveness of Pregabalin Versus Gabapentin for Peripheral Neuropathic Pain (pNeP) and Postherpetic Neuralgia (PHN) in China
Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting
Pregabalin and Gabapentin in Patients with Spinal Cord Injury-Related Neuropathic Pain: A Network Meta-Analysis
Retracted: Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
Retraction Note: Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
Real-World Treatment of Post-herpetic Neuralgia with Gabapentin or Pregabalin
Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial
Gabapentin and pregabalin exposures reported to United States poison centers, 2012–2022
Correction to: Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial
Comment on “Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update”
Pregabalin and gabapentin for chronic low back pain without radiculopathy: a systematic review
Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy
The Cost-Effectiveness of Pregabalin Versus Gabapentin for Peripheral Neuropathic Pain (pNeP) and Postherpetic Neuralgia (PHN) in China
Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting
Pregabalin and Gabapentin in Patients with Spinal Cord Injury-Related Neuropathic Pain: A Network Meta-Analysis
Retracted: Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
Retraction Note: Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
Real-World Treatment of Post-herpetic Neuralgia with Gabapentin or Pregabalin
Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial
Gabapentin and pregabalin exposures reported to United States poison centers, 2012–2022
Correction to: Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial
Comment on “Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update”
Pregabalin and gabapentin for chronic low back pain without radiculopathy: a systematic review
Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy
The Cost-Effectiveness of Pregabalin Versus Gabapentin for Peripheral Neuropathic Pain (pNeP) and Postherpetic Neuralgia (PHN) in China
Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting
Pregabalin and Gabapentin in Patients with Spinal Cord Injury-Related Neuropathic Pain: A Network Meta-Analysis
Retracted: Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
Retraction Note: Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
Real-World Treatment of Post-herpetic Neuralgia with Gabapentin or Pregabalin
Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial
Gabapentin and pregabalin exposures reported to United States poison centers, 2012–2022
Correction to: Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial
Comment on “Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update”